Consulting’s Role in Life Sciences: Lessons from Pfizer’s COVID-19 Response

This reflective report explores the role of consulting in the life sciences sector, with a focus on Pfizer's response to the COVID-19 pandemic. It examines how consulting helped Pfizer optimise R&D, navigate regulatory challenges, and create effective market strategies, setting a precedent for handling future public health crises. Key ethical considerations, such as patient privacy, equity in healthcare access, and transparency, are also addressed. Personal reflections highlight the importance of strategic thinking, problem-solving, and the promotion of CSR and ethical practices in the life sciences consulting field.